These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2253446)

  • 1. Drugs-of-abuse testing. Screening and confirmation.
    Aziz K
    Clin Lab Med; 1990 Sep; 10(3):493-502. PubMed ID: 2253446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gas chromatography/mass spectrometry. Instrumental techniques in forensic urine drug testing.
    Lehrer M
    Clin Lab Med; 1998 Dec; 18(4):631-49. PubMed ID: 9891603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18230-4. PubMed ID: 11010623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recovery of illicit drugs from oral fluid sampling devices.
    Dickson S; Park A; Nolan S; Kenworthy S; Nicholson C; Midgley J; Pinfold R; Hampton S
    Forensic Sci Int; 2007 Jan; 165(1):78-84. PubMed ID: 16621382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine testing in the detection of drugs of abuse.
    Schwartz RH
    Arch Intern Med; 1988 Nov; 148(11):2407-12. PubMed ID: 3056313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-site drug testing.
    Drummer OH
    Bull Narc; 2005; 57(1-2):205-11. PubMed ID: 21338022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification.
    Maralikova B; Weinmann W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):21-30. PubMed ID: 15458717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of drug intoxication using novel NAGINATA gas chromatography/mass spectrometry software.
    Ishida T; Kudo K; Naka S; Toubou K; Noguchi T; Ikeda N
    Rapid Commun Mass Spectrom; 2007; 21(18):3129-38. PubMed ID: 17708528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse in the workplace.
    Lubran MM; Jasper KT
    Ann Clin Lab Sci; 1988; 18(1):6-12. PubMed ID: 3355097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs of abuse in urine: some pitfalls in testing.
    Bosomworth MP
    Br J Biomed Sci; 1993 Jun; 50(2):150-5. PubMed ID: 8219920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
    Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
    Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodology and problems in the study of drugs of abuse in urine].
    Sieghart W
    Wien Klin Wochenschr; 1986 Jun; 98(13):411-6. PubMed ID: 2875564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of tandem mass spectrometry combined with gas chromatography and headspace solid-phase dynamic extraction for the determination of drugs of abuse in hair samples.
    Lachenmeier DW; Kroener L; Musshoff F; Madea B
    Rapid Commun Mass Spectrom; 2003; 17(5):472-8. PubMed ID: 12590396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desorption electrospray ionization mass spectrometry: direct toxicological screening and analysis of illicit Ecstasy tablets.
    Leuthold LA; Mandscheff JF; Fathi M; Giroud C; Augsburger M; Varesio E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2006; 20(2):103-10. PubMed ID: 16331738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.